Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
VJHemOnc is proud to be an official media partner for iwCAR-T 2021, a high-level discussion forum for research leaders in the field of CAR-T. Some of the world’s leading clinical researchers in the field will share their perspectives on how to place this evolving understanding in a clinical context and thereby optimize clinical care. The overriding objectives of the iwCAR-T are to facilitate global scientific interaction and exchange focusing on top-tier research endeavors.
The iwCAR-T 2021 meeting Scientific Committee has targeted areas for discussion where new evidence, insights, therapies and approaches, have important clinical implications, including:
10.00:10:05 EST Introduction & Meeting Objectives: John Gribben & David Maloney
10.05-11.00 Session 1: CAR-T in AML | Chairs: Saar Gill & John DiPersio
Panel discussion
11:00-12:20 Session 2: CAR-T in ALL | Chairs: Noelle Frey & Bijal Shah
CAR-T in ALL:
Panel Discussion
12.20-13:20 Session 3: CAR-T in CLL | Chairs: John Gribben & David Porter
Panel Discussion
Day 1, Conclusions & Wrap up
10.00am EST Introduction/Welcome
10.00-11:20 Session 4: CAR-T in Myeloma | Chairs: Yi Lin & Noopur Raje
Panel Discussion
11.20-12:45 Session 5: Evolution of cellular therapies | Chairs: David Maloney & Yi Lin
Panel Discussion
Day 2, Conclusions & Wrap up
10.00am EST Welcome/Introduction
10.00-11:45 Session 6: Where are we with emerging cell therapies in solid tumors? | Chairs: Stanley Riddell & Jennifer Specht
Panel Discussion
Panel Discussion
11.45-13:00 Session 7: Lymphoma | Chair: Frederick Locke & Caron Jacobson
Panel Discussion
Panel Discussion
Day 3, Conclusions & Wrap up
END